Table 2.
Control group (n = 64) |
Acarbose group (n = 60) |
|
---|---|---|
Cardiovascular death, n (%) | 5 (7.81) | 3 (5.00) |
Nonfatal reinfarction, n (%) | 7 (10.94) | 2 (3.33) |
New-onset angina, n (%) | 9 (14.06) | 5 (8.33) |
Cerebral stroke, n (%) | 4 (6.25) | 2 (3.33) |
Severe heart failure, n (%) | 5 (7.81) | 4 (6.67) |
Total MACE, n (%) | 30 (46.88) | 16 (26.67) |
MACE: major adverse cardiovascular events.